Zoetis Receives FDA Approval for Parasite Prevention Drug for Dogs

Zoetis Receives FDA Approval for Parasite Prevention Drug for Dogs

Source: 
Motley Fool
snippet: 

Zoetis (NYSE: ZTS) announced on Thursday that its new all-in-one parasite protection treatment for dogs had received approval from the U.S. Food and Drug Administration. Simparica Trio is a once-per-month chewable tablet that protects dogs from three prominent types of parasites common to canines, heartworm disease, fleas, and ticks.